Established in 2008, the Singapore Clinical Research Institute (SCRI) was set up as the national academic clinical research organisation to enhance the standards of clinical research in Singapore by developing core capabilities, infrastructure and scientific leadership for clinical research.
In 2021, SCRI was appointed as the national coordinating body to implement the national clinical trial strategy and enhance Singapore’s clinical trial ecosystem.
This is accomplished through the deployment of innovative technologies and processes, and strategic coordination of ecosystem capabilities and infrastructure to achieve synergies that will enhance the clinical research ecosystem aimed towards a healthier community and better patient outcomes.
SCRI’s key pillars include:
- Clinical Research Operations
- Clinical Trials Infrastructure Coordination
- Clinical Research Networks
- Academic Research Partnerships
- SCRI Academy
SCRI supports clinical trials and research in the domains of haematology and oncology, infectious diseases, ophthalmology, neuroscience, and cardiovascular.
For more information, please visit the SCRI website.